Clinical Trial Update: ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL [NA]

View source ↗

Summary

This clinical trial is evaluating a combination of ABL and JAK inhibitors with chemotherapy and venetoclax for Philadelphia-like acute lymphoblastic leukemia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia-like Acute Lymphoblastic Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)
• Ruxolitinib (ruxolitinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Ph-Like, Acute Lymphoblastic Leukemia | NA | Status: NOT_YET_RECRUITING